Microbot Medical Inc. Cash Flow Statement
MBOT|5 years of annual SEC 10-K data (FY2011-FY2015)
Covers operating cash flow, capital expenditures, free cash flow, share buybacks, and dividends paid across 5 fiscal years. All figures from audited SEC 10-K filings.
Microbot Medical Inc. used $23M in operating cash flow and negative free cash flow of $28M in FY2015.
Based on SEC 10-K filings.
Key Data Points
- Altman Z-Score -2.00 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
| Item | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|
| Net Income | -$26.4M | -$28.5M | -$21.3M | -$25.2M | -$27.0M |
| Depreciation & Amortization | $1.1M | $991.7K | $1.2M | $1.5M | $1.7M |
| Operating Cash Flow | -$23.3M | -$19.9M | -$22.1M | -$24.5M | -$24.7M |
| Capital Expenditures | $4.7M | $73.1K | $296.9K | $924.0K | $701.2K |
| Free Cash Flow | -$28.0M | -$19.9M | -$22.4M | -$25.4M | -$25.4M |
| FCF Margin | -16252.6% | -83093.4% | -1831.4% | -1783.1% | -2556.6% |